We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
| Share Name | Share Symbol | Market | Type |
|---|---|---|---|
| Lucira Health Inc | NASDAQ:LHDX | NASDAQ | Common Stock |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 0.4523 | 0.4451 | 0.448 | 0 | 01:00:00 |
From Jun 2022 to Jun 2024
By Dia Gill
Lucira Health Inc. shares soared 340.7% to 62 cents Monday morning after the medical technology company announced it was seeking a strategic partner to help resume manufacturing of its recently approved Covid-19 & Flu test.
The company's stock more than doubled Friday after the Food and Drug Administration issued emergency authorization of its Covid-19 & Flu test, the first at-home test able to detect the flu, and the first test able to detect and differentiate between the flu and Covid-19.
Just days ahead of the FDA's authorization, Lucira filed for Chapter 11 bankruptcy. At the time, the company said it would continue its operations during the bankruptcy process, while seeking a sale of its business.
The company's stock is up 1.5% since the start of the year and down 88% since one year ago.
Write to Dia Gill at dia.gill@wsj.com
(END) Dow Jones Newswires
February 27, 2023 09:57 ET (14:57 GMT)
Copyright (c) 2023 Dow Jones & Company, Inc.
1 Year Lucira Health Chart |
1 Month Lucira Health Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
